BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16941711)

  • 1. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice.
    Crettaz J; Berraondo P; Mauleón I; Ochoa-Callejero L; Shankar V; Barajas M; van Rooijen N; Kochanek S; Qian C; Prieto J; Hernández-Alcoceba R; González-Aseguinolaza G
    Hepatology; 2006 Sep; 44(3):623-32. PubMed ID: 16941711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.
    Tao N; Gao GP; Parr M; Johnston J; Baradet T; Wilson JM; Barsoum J; Fawell SE
    Mol Ther; 2001 Jan; 3(1):28-35. PubMed ID: 11162308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
    Bramson JL; Hitt M; Gauldie J; Graham FL
    Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.
    Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S
    Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of BMP-2 gene transfer on bone healing in sheep.
    Egermann M; Lill CA; Griesbeck K; Evans CH; Robbins PD; Schneider E; Baltzer AW
    Gene Ther; 2006 Sep; 13(17):1290-9. PubMed ID: 16642029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
    Stein CS; Pemberton JL; van Rooijen N; Davidson BL
    Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
    Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF
    Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
    Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
    Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing retention of adenovirus within tumours following direct intratumoural injection.
    Bazan-Peregrino M; Carlisle RC; Purdie L; Seymour LW
    Gene Ther; 2008 May; 15(9):688-94. PubMed ID: 18288207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
    Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
    Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vector-mediated gene transfer to regional lymph nodes.
    Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
    Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
    Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
    Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.